CareCloud, Inc. (CCLD)
NASDAQ: CCLD · Real-Time Price · USD
2.820
-0.030 (-1.05%)
Nov 22, 2024, 4:00 PM EST - Market closed
CareCloud Revenue
CareCloud had revenue of $28.55M in the quarter ending September 30, 2024, a decrease of -2.51%. This brings the company's revenue in the last twelve months to $111.01M, down -8.39% year-over-year. In the year 2023, CareCloud had annual revenue of $117.06M, down -15.68%.
Revenue (ttm)
$111.01M
Revenue Growth
-8.39%
P/S Ratio
0.41
Revenue / Employee
$30,837
Employees
3,600
Market Cap
45.80M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 117.06M | -21.77M | -15.68% |
Dec 31, 2022 | 138.83M | -773.00K | -0.55% |
Dec 31, 2021 | 139.60M | 34.48M | 32.80% |
Dec 31, 2020 | 105.12M | 40.68M | 63.13% |
Dec 31, 2019 | 64.44M | 13.89M | 27.49% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
SHL Telemedicine | 55.94M |
Verrica Pharmaceuticals | 9.21M |
SCYNEXIS | 8.57M |
Shattuck Labs | 6.44M |
OncoCyte | 709.00K |
CollPlant Biotechnologies | 689.00K |
Nexalin Technology | 162.08K |
Actinium Pharmaceuticals | 81.00K |
CCLD News
- 11 days ago - CareCloud, Inc. (CCLD) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 11 days ago - CareCloud Reports Third Quarter 2024 Results - GlobeNewsWire
- 7 weeks ago - CareCloud and ChartSwap Partner to Launch "CareCloud Powered by ChartSwap" to Streamline the Request for Information Process - GlobeNewsWire
- 2 months ago - CareCloud Announces Approval of Series A Preferred Stock Proposal - GlobeNewsWire
- 3 months ago - Support for Preferred Stock Proposal Hits a New High of 89%, Special Meeting Scheduled for September 11th - GlobeNewsWire
- 3 months ago - CareCloud, Inc. (CCLD) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - CareCloud To Announce Second-Quarter 2024 Results on August 13, 2024 - GlobeNewsWire
- 4 months ago - Voting on CareCloud's Series A Proxy Continues with 82% of Early Proxies Favoring the Proposal - GlobeNewsWire